Potential application of dot-immunobinding assay as a rapid diagnostic test in tuberculous meningitis

Area of Science:

• Immunology
• Infectious Diseases
• Neurology

Background:

• Tuberculous meningitis (TBM) is a severe form of tuberculosis affecting the central nervous system.
• Accurate and rapid diagnostic methods for TBM are crucial for timely treatment and improved patient outcomes.
• Current diagnostic approaches for TBM can be invasive and time-consuming.

Purpose of the Study:

• To develop and evaluate a simple dot-immunobinding assay (Dot-Iba) for detecting specific IgG antibodies against Mycobacterium tuberculosis antigens in cerebrospinal fluid (CSF).
• To assess the sensitivity of the Dot-Iba assay in diagnosing tuberculous meningitis (TBM).

Main Methods:

• A dot-immunobinding assay (Dot-Iba) was developed using nitrocellulose paper.
• The assay targeted the detection of specific IgG antibodies to Mycobacterium tuberculosis antigen 5 and general mycobacterial antigens in CSF samples.
• Sensitivity was calculated based on confirmed TBM cases.

Main Results:

• The Dot-Iba assay demonstrated a sensitivity of 77.1% for detecting IgG antibodies to Mycobacterium tuberculosis antigen 5 in TBM patients.
• The sensitivity for detecting general mycobacterial antigens in TBM patients was 48.6%.
• The assay provides a potential tool for TBM diagnosis using CSF.

Conclusions:

• The developed Dot-Iba assay is a potentially valuable tool for the immunodiagnosis of tuberculous meningitis.
• Detection of IgG antibodies to Mycobacterium tuberculosis antigen 5 shows higher sensitivity compared to general mycobacterial antigens in TBM patients.
• Further validation and optimization of the Dot-Iba assay are warranted for clinical application in TBM diagnosis.